Introduction
Although environmental factors are clearly important determinants of obesity susceptibility, a signi®cant hereditary contribution to the etiology of obesity has been suggested by several studies. 1 ± 3 However, the inheritance of obesity does not follow the classical Mendelian patterns that are characteristic of single-gene disorders. It is clear that multiple regions of the genome are likely to contain susceptibility genes for obesity and associated phenotypes. 4 ± 6 Tumor necrosis tumor-alpha (TNF-a), acting as a modulator of gene expression in adipocytes, is involved in the development of insulin resistance and obesity. In rats, administration of TNF-a results in elevated levels of serum triglycerides. 7 In murine adipocytes, TNF-a is capable of suppressing the expression of adipocyte-speci®c expression such as lipoprotein lipase 8 and the enzymes involved in fatty acid biosynthesis. 9 ,10 TNF-a is highly expressed in fat tissue of obese humans. 11 Similar increases were also observed in adipose tissue production of TNF-a. 11 These studies, along with the ®nding showing a linkage of obesity to the chromosomal region 6p21. 3, 12 suggest that TNF-a andaor a nearby gene is involved in the onset and progression of weight gain.
The gene for TNF-a resides within the class III region of the major histocompatibility complex (MHC). A polymorphism directly affecting the regulation of TNF-a is located at 7308 nucleotides relative to the transcriptional start site of the gene. 13 There are two allelic forms, referred to as TNF1 and TNF2. The TNF2 allele is associated with higher constitutive and inducible levels of TNF-a. 14 These observations raise the possibility that obesity development is related to the genetic propensity of the host to produce high level of TNF-a. Thus, we assessed the polymorphism of TNF-a gene in patients with obesity and in healthy subjects. In the MHC, the TNF genes are located telomeric to three intronless genes encoding members of heat shock proteins (hsp70). These have been de®ned as hsp70-1, hsp70-2 and hsp70-hom. 15, 16 The hsp70-1 and hsp70-2 genes have been shown to encode an identical protein, which is the major heat-inducible hsp70 protein. 17 The hsp70-hom encodes a protein, which shares 90% sequence identity with hsp70 protein. the synthesis of heat shock proteins (stress proteins) can be induced in eukaryotic cells after exposure to a variety of environmental and pathophysiologic stressful conditions. 18 ± 20 The group of the 70 kDa family (hsp70) consists of members that show the general characterisitic of protecting cell proteins from damage caused by various stressful stimuli by binding to denatured or inappropriately folded proteins. 21 Several reports indicate a potential role of hsp70 stress proteins in regulatory processes of TNF-a expression and function. 22 ± 25 The aim of this study was to assess the degree of the TNF-a and hsp70-2 gene polymorphism in healthy subjects and in patients with obesity in Tunisia.
Methods

Patients and controls
The gene and allele frequencies of the TNF-a and hsp70-2 genes were determined in a group of 174 control subjects and 343 patients with obesity. Controls and patients were selected from the same population living in the region of Tunis. Both control and patient groups include unrelated subjects.
Patients were recruited from the department of Nutrition at Institut National de Nutrition of Tunis. The body mass index (BMI) classi®cations and obesity de®ntion were made according to Wensier. 26 The patients (290 women and 53 men) had a mean ( AE s.d.) BMI of 36.8 AE 6 and a mean age of 36 AE 12 y. Sixty-four patients (19%) had type 2 diabetes. All the patients underwent physical examination and a questionnaire was used which included a full history related to obesity and diabetes.
Control subjects (75 females and 99 males) having a mean BMI of 22 AE 2.6 and a mean age of 39 AE 12 y, were unrelated healthy blood donors having no evidence of any personal or family history of obesity or diabetes (or other serious illness). Informed consent was obtained from all participants.
DNA extraction
Genomic DNA was extracted from peripheral blood leukocytes by a salting out procedure. 27 Brie¯y, 5 ml of blood was mixed with Triton lysis buffer (0.32 M sucrose, 1% Triton X-100, 5 mM MgCl 2 , H 2 O, 10 mM Tris ± HCl, pH 7.5). Leukocytes were spun down and washed with H 2 O. The pellet was incubated with proteinase K at 56 C and subsequently salted out at 4 C using a saturated NaCl solution. Precipitated proteins were removed by centrifugation. The DNA in the supernatant was precipitated with ethanol. The DNA pellet was dissolved in 400 ml H 2 O.
Ampli®ed fragment length polymorphism of the TNF-a gene Based upon the method described by Cabrera et al, 28 a polymerase chain reaction followed by digestion with the endonuclease NcoI was used to detect the G to A transition polymorphism at position 7308 of TNF-a gene. Two sequence speci®c oligonucleotide primers were used for the PCR: the 3 Ampli®ed fragment length polymorphism of the hsp70-2 gene Polymorphism within hsp70-2 gene has been characterized by Milner et al, 29 who identi®ed a polymorphic PstI site at position 1267 of the hsp70-2 gene. The position 1267 of the hsp70-2 gene lies in the coding region, but correspond to silent mutation. The coding sequence of the hsp70-2 gene was ampli®ed from genomic DNA using sequence-speci®c oligonucleotide primers: the 5 H -primer, 5 H -TCCGAAGGACT-GAGCTCTTG-3
H , was used in combination with the 3 Hprimer, 5
H -CAGCAAAGTCCTTGAGTCCC. The PCR reactions mixture contained 500 ng of genomic DNA; 200 mmolal dNTPs; 1.5 mM MgCl 2 ; 1ÂTaq DNA polymerase buffer; 1 mmol each primer; and 1 unit of Taq DNA polymerase (Amersham, France). Ampli®cation was accomplished by initial incubation at 94 C for 5 min followed by 20 cycles of incubation at 94 C for 1 min; 60 C for 1 min; and 72 C for 3 min, followed by a ®nal incubation at 72 C for 10 min.
Statistical analyses
The chi-square test was used to test for signi®cant association between disease (obesity against controls) and TNF-a or hsp70-2 alleles or genotypes. Relative risk of obesity with a
International Journal of Obesity TNF-a and hsp70 polymorphism in obesity L Chouchane et al particular genotype was estimated by the odds ratio (OR) formula: 30 OR n1 Á n2an3 Á n4 where n1 is the proportion of patients with obesity carrying the allele, n2 is the proportion of control subjects with the genotype, and n3 and n4 are the corresponding proportions of individuals in patient and control groups without the genotype. The OR was tested by using a chi-square distribution, and the null hypothesis being tested was OR 1. 31 Statistics were performed by use of Epi Info 6 software, version 6.0 (CDC, USA; WHO, Switzerland).
Results
No association between obesity and TNF-a polymorphism The distribution of TNF-a genotypes in the patient group and the control group is shown in Table 1 . Although the gene frequency of the TNF2 allele was higher in obese subjects than in controls (0.207 vs 0.175), the difference did not reach statistical signi®cance (P 0.21). No signi®cant differences in the TNF-a genotypes distribution were seen between patients and controls. Thus, there was no direct correlation between the presence of the TNF2 allele and the development of obesity. Since TNF2 homozygous genotype was associated with excessive fat accumulation in Swedish women, 32 we satrati®ed the obese and the non-obese subjects according to gender. No signi®cant differences in TNF-a genotype distributions were found between the subgroups.
Further analysis revealed that the mean BMI in obese patients with the TNF2 allele was slightly higher than that in patients without the TNF2 allele (35 AE 6 vs 34.3 AE 5, P 0.246). The mean weight was higher in the patient group carrying the TNF2 allele without reaching statistical signi®cance (92 AE 17 kg vs 89 AE 13 kg, P 0.06). There were The chi-square test with Yates' correction was used to determine whether signi®cant differences (P-value) were observed when patient groups were compared with control groups. NS, not signi®cant; f, frequencies. The chi-square test with Yates' correction was used to determine whether signi®cant differences (P-value) were observed when patient groups were compared with control groups. NS, not signi®cant; f, frequencies. International Journal of Obesity TNF-a and hsp70 polymorphism in obesity L Chouchane et al no discernible differences between the two groups of patients in the age at the onset of obesity or frequency of diabetes.
Association between obesity and hsp70-2 polymorphism Table 2 shows genotype frequencies for hsp70-2 in the patient group and the control group. The allele frequency of the hspP2 was 0.564 in patients with obesity and 0.425 in control subjects (P 0.0002). The frequency of P1aP2 heterozygotes was 0.568 in patients and 0.747 in the control population (P 0.0006), resulting to a signi®cant negative risk associated with this genotype. Conversely, the frequency of the P2aP2 homozygotes was 0.280 in patient group and only 0.052 in controls. These results indicate that the relative risk of obesity associated with the hsp70-2 polymorphism is con®ned to P2aP2 homozygotes (r 2 7.12, P`10
76
). Analysis of the demographic and clinical characteristics of obese patients with or without the hsp70-2 P2aP2 genotype is shown in Table 3 . The mean BMI in obese patients with the P2aP2 genotype was signi®cantly higher than that in patients without the P2aP2 genotype (37.1 AE 5.3 vs 33.2 AE 4.2, P`10 76 ). The mean weight was signi®cantly higher in the patient group carrying the P2aP2 genotype (94 AE 14 vs 87 AE 13 kg, P 0.0048). There were no signi®cant differences between the two groups of patients in the age at the onset of obesity or frequency of diabetes.
Discussion
Given the potential role of TNF-a in development of insulin resistance and obesity, the TNF-a gene could conceivably be a candidate gene for obesity. In a sib-pair linkage analysis, a percentage body fat, as measured by hydrostatic weighing, was linked to a marker nearby the TNF-a gene. 12 In a small cohort, the ±308 TNF-a polymorphism was found to be associated with insulin resistance, and increased percentage body fat and high serum leptin levels. 33 The present casecontrolled study indicated no direct correlation between the ±308 TNF-a promoter polymorphism and obesity. A polymorphism analysis of the TNF-a promoter, presumably the one analyzed in this study, also showed a lack of association between the TNF-a marker and obesity in Pima Indians. 12 More recently, it has been shown in a large cohort that 7308 TNF-a polymorphism does not associate with traits related to obesity and insulin resistance. 34,35. Taken together, these results suggest that the observed linkage of TNF-a to obesity 12 might be due to a sequence variant undetected in TNF-a gene or due to a variant in some other closely linked genes. Thus, we analyzed a potential association of polymorphism of stress protein, hsp70-2, whose gene is physically linked to TNF-a.
Comparison of hsp70-2 genotype frequencies in patients with obesity and control subjects indicated a decrease of P1aP1 and P1aP2 genotypes in the group with obesity, resulting in a decrease of the P1 allele in this group. This result suggests that this allele may be considered as a protective marker against obesity. Conversely, a high r 2 of obesity was associated with the P2aP2 homozygous genotype. Although the hsp70 polymorphism analyzed in the present study corresponds to silent mutation, it was associated with higher expression of hsp70. 36 It is most likely that this polymorphism is in linkage disequilibrium with a functional polymorphism within the hsp70 gene. The other possible explanation for the association found between hsp70-2 polymorphism and obesity is that hsp70 P2 allele is not involved causally in contributing to the obesity onset, but it is in linkage disequilibrium with a nearby gene in chromosome 6p. Several candidates, notably those of HLAclass II and -class III, may be involved in the linkage disequilibrium with the hsp70-2 polymorphism. There is a reported association of HLA antigens with BMI among subjects of the Framingham Heart Study. 37 Analysis of the demographic and clinical characteristics of obese patients with or without the hsp70-2 P2aP2 genotype indicated that the hsp70-2 P2aP2 genotype is speci®cally associated with an increased capacity to gain weight, yielding high values of BMI.
The level of expression of hsp70 genes could be among factors affecting the regulation of thermogenesis and lipolysis in adipose tissue or other mechanisms exacerbating the obesity. It has been shown that hsp70 plays a role in the folding, subcellular localization and activation of the peroxisome proliferator-activated receptors. 38 These receptors, in particular the gamma isoform, play a major role in adipose tissue formation and insulin sensitivity. 39 Such ®ndings raise the possibility that the activation of these receptors might depend on the hsp70 phenotypes.
Although this study showed a highly signi®cant association of the hsp70-2 polymorphism with obesity in Tunisians, further studies are needed to clarify the role of this polymorphism in the pathogenesis of the disease. Replication of our ®ndings in other populations will be of use in determining whether the relations between the hsp70-2 marker and the development of obesity and its clinical phenotypes can be generalized.
